Stefano Cipollari1,2, Neema Jamshidi1,3, Liutao Du3, Kyunghyun Sung3, Danshan Huang3, Daniel J Margolis4, Jiaoti Huang5, Robert E Reiter6, Michael D Kuo1. 1. Medical Artificial Intelligence Laboratory Program, The University of Hong Kong, Hong Kong, Hong Kong SAR. 2. Department of Radiology, La Sapienza, The University of Rome, Rome, Lazio, Italy. 3. Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, California, USA. 4. Department of Radiology, Cornell University, New York, New York, USA. 5. Department of Pathology, Duke University School of Medicine, Durham, North Carolina, USA. 6. Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Abstract
BACKGROUND: Tissue clearing technologies have enabled remarkable advancements for in situ characterization of tissues and exploration of the three-dimensional (3D) relationships between cells, however, these studies have predominantly been performed in non-human tissues and correlative assessment with clinical imaging has yet to be explored. We sought to evaluate the feasibility of tissue clearing technologies for 3D imaging of intact human prostate and the mapping of structurally and molecularly preserved pathology data with multi-parametric volumetric MR imaging (mpMRI). METHODS: Whole-mount prostates were processed with either hydrogel-based CLARITY or solvent-based iDISCO. The samples were stained with a nuclear dye or fluorescently labeled with antibodies against androgen receptor, alpha-methylacyl coenzyme-A racemase, or p63, and then imaged with 3D confocal microscopy. The apparent diffusion coefficient and Ktrans maps were computed from preoperative mpMRI. RESULTS: Quantitative analysis of cleared normal and tumor prostate tissue volumes displayed differences in 3D tissue architecture, marker-specific cell staining, and cell densities that were significantly correlated with mpMRI measurements in this initial, pilot cohort. CONCLUSIONS: 3D imaging of human prostate volumes following tissue clearing is a feasible technique for quantitative radiology-pathology correlation analysis with mpMRI and provides an opportunity to explore functional relationships between cellular structures and cross-sectional clinical imaging.
BACKGROUND: Tissue clearing technologies have enabled remarkable advancements for in situ characterization of tissues and exploration of the three-dimensional (3D) relationships between cells, however, these studies have predominantly been performed in non-human tissues and correlative assessment with clinical imaging has yet to be explored. We sought to evaluate the feasibility of tissue clearing technologies for 3D imaging of intact human prostate and the mapping of structurally and molecularly preserved pathology data with multi-parametric volumetric MR imaging (mpMRI). METHODS: Whole-mount prostates were processed with either hydrogel-based CLARITY or solvent-based iDISCO. The samples were stained with a nuclear dye or fluorescently labeled with antibodies against androgen receptor, alpha-methylacyl coenzyme-A racemase, or p63, and then imaged with 3D confocal microscopy. The apparent diffusion coefficient and Ktrans maps were computed from preoperative mpMRI. RESULTS: Quantitative analysis of cleared normal and tumor prostate tissue volumes displayed differences in 3D tissue architecture, marker-specific cell staining, and cell densities that were significantly correlated with mpMRI measurements in this initial, pilot cohort. CONCLUSIONS: 3D imaging of human prostate volumes following tissue clearing is a feasible technique for quantitative radiology-pathology correlation analysis with mpMRI and provides an opportunity to explore functional relationships between cellular structures and cross-sectional clinical imaging.
Authors: J B Welsh; L M Sapinoso; A I Su; S G Kern; J Wang-Rodriguez; C A Moskaluk; H F Frierson; G M Hampton Journal: Cancer Res Date: 2001-08-15 Impact factor: 12.701
Authors: Junqian Xu; Peter A Humphrey; Adam S Kibel; Abraham Z Snyder; Vamsidhar R Narra; Joseph J H Ackerman; Sheng-Kwei Song Journal: Magn Reson Med Date: 2009-04 Impact factor: 4.668
Authors: Maximilian Diehn; Christine Nardini; David S Wang; Susan McGovern; Mahesh Jayaraman; Yu Liang; Kenneth Aldape; Soonmee Cha; Michael D Kuo Journal: Proc Natl Acad Sci U S A Date: 2008-03-24 Impact factor: 11.205
Authors: Neema Jamshidi; Eric Jonasch; Matthew Zapala; Ronald L Korn; James D Brooks; Borje Ljungberg; Michael D Kuo Journal: Eur Radiol Date: 2015-11-11 Impact factor: 5.315
Authors: Eline K Vos; Geert J S Litjens; Thiele Kobus; Thomas Hambrock; Christina A Hulsbergen-van de Kaa; Jelle O Barentsz; Henkjan J Huisman; Tom W J Scheenen Journal: Eur Urol Date: 2013-05-31 Impact factor: 20.096